Abstract
Since the advent of the phenylketonuria screen for newborns in the 1960s, there has been an explosion of new tests for the early detection of numerous genetic, cardiac, and metabolic diseases. The intent is to discover and treat these illnesses before symptoms develop and to prevent possible irreparable harm. Screenings are typically conducted with parental assent rather than explicit consent. However, parental refusal on the grounds of personal and religious beliefs are becoming increasingly more common.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
